U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived - Fluticasone propionate - Document - PDFSEARCH.IO

First Page	Meta Content
	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived Add to Reading List Open Document File Size: 441,17 KB Share Result on Facebook City SalmeterolContaining Dispensings / / Company GlaxoSmithKline / Glaxosmithkline plc / / Continent Europe / / Country United States / / Event FDA Phase / / IndustryTerm combination products / fixed-dose combination products / / MedicalCondition asymptomatic asthma / OF ASTHMA / disease / asthma / / Organization U.S. Food and Drug Administration / Stanford / FDA Joint Advisory Committee / / Product fluticasone propionate / SEREVENT / SEREVENT® Nationwide Surveillance Study / / SocialTag GlaxoSmithKline Asthma Fluticasone/salmeterol Salmeterol Fluticasone propionate Montelukast Randomized controlled trial Long-acting beta-adrenoceptor agonist Pulmonology Respiratory therapy

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archivedAdd to Reading List